RSS-Feed abonnieren
DOI: 10.1055/s-2007-963558
© Georg Thieme Verlag KG Stuttgart · New York
Incidence, Clinical Management and Outcomes of Esophageal Perforations after Endoscopic Dilatation
Inzidenz, Management und Verlauf von Perforationen des Ösophagus nach endoskopischer DilatationPublikationsverlauf
manuscript received: 13.7.2007
manuscript accepted: 5.9.2007
Publikationsdatum:
19. November 2007 (online)

Zusammenfassung
Einleitung: Endoskopische Dilatationen werden bei der Behandlung von anatomischen und selten funktionellen Stenosierungen des Ösophagus eingesetzt, die durch eine Vielzahl von benignen oder malignen Prozessen verursacht sein können. Die Ösophagusperforation ist dabei die bedeutendste, assoziierte Komplikation. Ziele: Bestimmung der Inzidenz von Perforationen nach endoskopischer Dilatation des Ösophagus, ihr Management und ihr Verlauf. Methodik: Alle Patienten, die in unserem Zentrum von Juni 2001 bis Dezember 2006 eine endoskopische Ösophagusdilatation erhielten, wurden prospektiv mittels elektronischer Datenbanksuche identifiziert und analysiert. Ergebnis: In dieser Studie wurden 248 Patienten (148 Männer; 100 Frauen; Altersmedian 58, Range 14 - 87), die insgesamt 365 Ösophagusdilatationen erhielten, eingeschlossen: 74 pneumatische Ballondilatationen bei Achalasie, 79 Ballondilatationen bei anderen Gründen, wie zum Beispiel aufgrund von Tumoren, peptischen oder postradiogenen Stenosen, und 212 Dilatationen erfolgten mit Savary-Bougies. Die gesamte Inzidenz an Perforationen, basierend auf der Anzahl der durchgeführten Prozeduren, betrug 2,2 % (8 Perforationen/ 365 Behandlungen). Bezogen auf die Gesamtzahl der betrachteten Patienten betrug die Perforationsrate 3,2 % (8 / 248 Patienten). Die Perforationsrate betrug 1,9 % bei Bougie-Dilatation, 0 % bei Ballondilatation und 5,4 % bei pneumatischer Ballondilatation aufgrund einer Achalasie. Fünf der betroffenen Patienten erhielten eine operative Versorgung, während drei Patienten konservativ behandelt wurden. Die mittlere Krankenhausverweildauer betrug 14 Tage (7 - 33). Ein Patient, bei dem die Perforation erst 16 Tage nach der Dilatation erkannt wurde, verstarb. Schlussfolgerung: Die endoskopische Ösophagusdilatation ist eine sichere Methode zur Behandlung sowohl von malignen als auch von benignen Stenosierungen des Ösophagus sowie bei Patienten mit einer Achalasie. Die Perforationsrate nach diesen Behandlungen ist gering und der Benefit des Patienten überwiegt gegenüber den Komplikationen. Die frühe Erkennung einer Perforation ist mit einem besseren Outcome für den Patienten verbunden und kleine Perforationen können konservativ behandelt werden.
Abstract
Background: Esophageal dilatation is performed for the treatment of anatomic and sometimes functional narrowing of the esophageal lumen caused by a variety of benign and malignant conditions. Esophageal perforation is the major complication associated with endoscopic dilatation. Aim: The object of this study was to assess the incidence of perforation, management and outcomes after endoscopic esophageal dilatation. Methods: All patients who underwent endoscopic esophageal dilatation at our institution from June 2001 to December 2006 were identified. Data were obtained by searching our prospectively collected electronic database (MEDOS AG, Langenselbold, Germany), which includes all endoscopic reports as well as discharge summaries of patients who have undergone endoscopy in our department. Results: 248 patients (148 male, 100 female, mean age 58 years, range 14 - 87 years) underwent 365 esophageal dilatations: 74 pneumatic balloon dilatations for achalasia, 79 balloon dilatations for other reasons such as tumors, peptic stenosis, or post-radiotherapy stenosis and 212 dilatations with Savary bougies. The overall incidence of perforation based on the number of procedures was 2.2 % (8 perforations/ 365 procedures) and 3.2 % (8 / 248 patients) based on the number of patients. The perforation rate was 1.9 % for bougie dilatation, 0 % for balloon dilatation and 5 - 4 % for pneumatic balloon dilatation for achalasia. Five patients were treated surgically and 3 patients were managed conservatively. The mean hospital stay was 14 days (7 - 33 days). One patient in whom the perforation was recognized 16 days after the dilatation died. Conclusions: Endoscopic esophageal dilatation is a safe procedure for the palliation of malignant strictures, for the management of benign strictures as well as for the therapy of achalasia. The perforation rate after these procedures is low. Early recognition of the perforation is associated with a good outcome. Small perforations can be treated conservatively.
Schlüsselwörter
endoskopische Ösophagusdilatation - Ösophagusperforation - Ösophagusstenose
Key words
endoscopic esophageal dilatation - esophagus perforation - esophageal stenosis
References
- 1
Lew R J, Kochman M L.
A review of endoscopic methods of esophageal dilatation.
J Clin Gastroenterol.
2002;
35
117-126
MissingFormLabel
- 2
Richter J E.
Peptic strictures of the esophagus.
Gastroenterol Clin North Am.
1999;
28
875-891
MissingFormLabel
- 3
Riley S A, Attwood S E.
Guidelines on the use of oesophageal dilatation in clinical practice.
Gut.
2004;
53
i1-i6
MissingFormLabel
- 4
Egan J V, Baron T H, Adler D G. Standards of Practice Committee et al .
Esophageal dilatation.
Gastrointest Endosc.
2006;
63
755-760
MissingFormLabel
- 5
Lavu K, Mathew T P, Minocha A.
Effectiveness of esophageal dilatation in relieving nonobstructive esophageal dysphagia
and improving quality of life.
South Med J.
2004;
97
137-140
MissingFormLabel
- 6
Adler D G, Baron T H.
Endoscopic palliation of malignant dysphagia.
Mayo Clin Proc.
2001;
76
731-738
MissingFormLabel
- 7
Pfau P R, Ginsberg G G, Lew R J. et al .
Esophageal dilatation for endosonographic evaluation of malignant esophageal strictures
is safe and effective.
Am J Gastroenterol.
2000;
95
2813-2815
MissingFormLabel
- 8
Adler D G, Baron T H, Geels W. et al .
Placement of PEG tubes through previously placed self-expanding esophageal metal stents.
Gastrointest Endosc.
2001;
54
237-241
MissingFormLabel
- 9
Vaezi M F, Richter J E.
Current therapies for achalasia: comparison and efficacy.
J Clin Gastroenterol.
1998;
27
21-35
MissingFormLabel
- 10
Mikaeli J, Bishehsari F, Montazeri G. et al .
Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and
efficacy with different balloon diameters.
Aliment Pharmacol Ther.
2004;
15
431-436
MissingFormLabel
- 11
Hernandez L V, Jacobson J W, Harris M S.
Comparison among the perforation rates of Maloney, balloon, and savary dilatation
of esophageal strictures.
Gastrointest Endosc.
2000;
51
460-462
MissingFormLabel
- 12
Portale G, Costantini M, Rizzetto C. et al .
Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: possible
detrimental role of previous endoscopic treatment.
J Gastrointest Surg.
2005;
9
1332-1339
MissingFormLabel
- 13
Metman E H, Lagasse J P, d’Alteroche L. et al .
Risk factors for immediate complications after progressive pneumatic dilatation for
achalasia.
Am J Gastroenterol.
1999;
94
1179-1185
MissingFormLabel
- 14
Quine M A, Bell G D, McCloy R F. et al .
Prospective audit of perforation rates following upper gastrointestinal endoscopy
in two regions of England.
Br J Surg.
1995;
82
530-533
MissingFormLabel
- 15
Jethwa P, Lala A, Powell J. et al .
A regional audit of iatrogenic perforation of tumours of the oesophagus and cardia.
Aliment Pharmacol Ther.
2005;
21
479-484
MissingFormLabel
- 16
McClave S A, Brady P G, Wright R A. et al .
Does fluoroscopic guidance for Maloney esophageal dilatation impact on the clinical
endpoint of therapy: relief of dysphagia and achievement of luminal patency.
Gastrointest Endosc.
1996;
43
93-97
MissingFormLabel
- 17
Saeed Z A, Winchester C B, Ferro P S. et al .
Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons
for dilatation of peptic strictures of the esophagus.
Gastrointest Endosc.
1995;
41
189-195
MissingFormLabel
- 18
Colon V J, Young M A, Ramirez F C.
The short- and long-term efficacy of empirical esophageal dilatation in patients with
nonobstructive dysphagia: a prospective, randomized study.
Am J Gastroenterol.
2000;
95
910-913
MissingFormLabel
- 19
Scolapio J S, Pasha T M, Gostout C J. et al .
A randomized prospective study comparing rigid to balloon dilators for benign esophageal
strictures and rings.
Gastrointest Endosc.
1999;
50
13-17
MissingFormLabel
- 20
Hirota K, Petersen K, Baron T H. et al .
Antibiotic prophylaxis for GI endoscopy.
Gastointest Endosc.
2003;
58
475-482
MissingFormLabel
- 21
Eisen G M, Baron T H, Dominitz J A. et al .
Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic
procedures.
Gastrointest Endosc.
2002;
55
775-779
MissingFormLabel
- 22
Clouse R E.
Complications of endoscopic gastrointestinal dilatation techniques.
Gastrointest Endosc Clin North Am.
1996;
6
323-341
MissingFormLabel
- 23
Ho S B, Cass O, Katsman R J. et al .
Fluoroscopy is not necessary for Maloney dilatation of chronic esophageal strictures.
Gastrointest Endosc.
1995;
42
11-14
MissingFormLabel
- 24
McLean G K, LeVeen R F.
Shear stress in the performance of esophageal dilatation: comparison of balloon dilatation
and bougienage.
Radiology.
1989;
172
983-986
MissingFormLabel
- 25
Fleischer D E, Benjamin S B, Cattau E L. et al .
A marked guide wire facilitates esophageal dilatation.
Am J Gastroenterol.
1989;
84
359-361
MissingFormLabel
- 26
Kadakia S C, Wong R K.
Graded pneumatic dilatation using Rigiflex achalasia dilators in patients with primary
esophageal achalasia.
Am J Gastroenterol.
1993;
88
34-38
MissingFormLabel
- 27
Marshall J B.
Pneumatic dilatation for achalasia after fundoplication.
J Clin Gastroenterol.
1989;
11
154-157
MissingFormLabel
- 28
Langdon D F.
The rule of three in esophageal dilatation.
Gastrointest Endosc.
1997;
45
111
MissingFormLabel
- 29
Vaezi M F, Richter J E.
Diagnosis and management of achalasia. American College of Gastroenterology Practice
Parameter Committee.
Am J Gastroenterol.
1999;
94
3406-3412
MissingFormLabel
- 30
Eckardt V F, Gockel Jr I, Bernhard G.
Pneumatic dilatation for achalasia: late results of a prospective follow up investigation.
Gut.
2004;
53
629-633
MissingFormLabel
- 31
Abid S, Champion G, Richter J E. et al .
Treatment of achalasia: the best of both worlds.
Am J Gastroenterol.
1994;
89
979-985
MissingFormLabel
- 32
Nair L A, Reynolds J C, Parkman H P. et al .
Complications during pneumatic dilatation for achalasia or diffuse esophageal spasm.
Analysis of risk factors, early clinical characteristics, and outcome.
Dig Dis Sci.
1993;
38
1893-1904
MissingFormLabel
- 33
Lambroza A, Schuman R W.
Pneumatic dilatation for achalasia without fluoroscopic guidance: safety and efficacy.
Am J Gastroenterol.
1995;
90
1226-1229
MissingFormLabel
- 34
Rai R R, Shende A, Joshi A. et al .
Rigiflex pneumatic dilatation of achalasia without fluoroscopy: a novel office procedure.
Gastrointest Endosc.
2005;
62
427-431
MissingFormLabel
- 35
Borotto E, Gaudric M, Danel B. et al .
Risk factors of oesophageal perforation during pneumatic dilatation for achalasia.
Gut.
1996;
39
9-12
MissingFormLabel
- 36
Fadoo F, Ruiz D E, Dawn S K. et al .
Helical CT esophagography for the evaluation of suspected esophageal perforation or
rupture.
Am J Roentgenol.
2004;
182
1177-1179
MissingFormLabel
- 37
Siersema P D, Homs M Y, Haringsma J. et al .
Use of large-diameter metallic stents to seal traumatic nonmalignant perforations
of the esophagus.
Gastrointest Endosc.
2003;
58
356-361
MissingFormLabel
- 38
Gelbmann C M, Ratiu N L, Rath H C. et al .
Use of self-expandable plastic stents for the treatment of esophageal perforations
and symptomatic anastomotic leaks.
Endoscopy.
2004;
36
695-699
MissingFormLabel
Klaus Mönkemüller, MD
Department of Gastroenterology, Hepatology and Infectious Diseases, Universitätsklinikum
Magdeburg, Otto-von-Guericke University
Leipziger Straße 44
39120 Magdeburg
Germany
Telefon: ++ 49/3 91/6 71 31 00
Fax: ++ 49/3 91/6 71 31 05
eMail: Klaus.Moenkemueller@medizin.uni-magdeburg.de